Goswami S

No ORCID on file · 4 papers in corpus
2022
VEGF-A controls the expression of its regulator of angiogenic functions, dopamine D2 receptor, on endothelial cells.
Journal of cell science ·doi:10.1242/jcs.259617

We have previously demonstrated significant upregulation of dopamine D2 (DAD2) receptor (DRD2) expression on tumor endothelial cells. The dopamine D2 receptors, upon activation, inhibit the proangiogenic actions of vascular endothelial grow…

2016
Osteoprotegerin rich tumor microenvironment: implications in breast cancer.
Oncotarget ·doi:10.18632/oncotarget.8658

Osteoprotegerin (OPG) is a soluble decoy receptor for tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL). It belongs to the tumor necrosis factor receptor superfamily (TNFRSF). OPG was initially discovered to contribute t…

2015
Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis.
BMC cancer ·doi:10.1186/s12885-015-1837-1

BackgroundOsteoprotegerin (OPG) is a glycoprotein that has multifaceted role and is associated with several cancer malignancies like that of bladder carcinoma, gastric carcinoma, prostate cancer, multiple myeloma and breast cancer. Also OPG…

2011
Hysterectomy…..Which route?
Journal of obstetrics and gynaecology of India ·doi:10.1007/s13224-011-0076-x

ObjectiveWe designed this study to focus on women with mobile uteri benign no larger than 14 weeks, who would ordinarily be considered candidates for vaginal hysterectomy and compare the outcomes when abdominal routes were chosen. We also c…